Covered recipient · General Payments record
DAVID ALEXANDER LEENEN
Allopathic & Osteopathic Physicians Surgery
General Payments · PY2022–2024
$1,803.77
- Reported across 23 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,054.72 | 16 |
| Travel and Lodging | $336.37 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Enterra Medical, Inc. | $1,020.84 | 4 |
| Ethicon US, LLC | $196.32 | 5 |
| Merck Sharp & Dohme Corporation | $68.86 | 3 |
| Lilly USA, LLC | $55.97 | 3 |
| ABBVIE INC. | $29.62 | 1 |
| Lucid Diagnostics Inc. | $19.48 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $29.62 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104157682 | CMS |
| Enterra Medical, Inc. | $573.77 | 10/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154811258 | CMS |
| Enterra Medical, Inc. | $336.37 | 10/19/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1154811260 | CMS |
| Enterra Medical, Inc. | $18.99 | 10/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154811262 | CMS |
| Enterra Medical, Inc. | $91.71 | 10/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154811264 | CMS |
| Ethicon US, LLC | $17.55 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077644948 | CMS |
| Ethicon US, LLC | $32.87 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077644940 | CMS |
| Ethicon US, LLC | $11.46 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077644950 | CMS |
| Ethicon US, LLC | $119.62 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077644926 | CMS |
| Ethicon US, LLC | $14.82 | 11/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077644952 | CMS |
| Lilly USA, LLC | $20.65 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136126137 | CMS |
| Lilly USA, LLC | $15.34 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136142209 | CMS |
| Lilly USA, LLC | $19.98 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136126139 | CMS |
| Lucid Diagnostics Inc. | $19.48 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152301663 | CMS |
| Merck Sharp & Dohme LLC | $16.28 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141808909 | CMS |
| Merck Sharp & Dohme LLC | $24.13 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141947885 | CMS |
| Merck Sharp & Dohme LLC | $28.45 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141808757 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.